Follow
Leonard Saltz
Leonard Saltz
Professor of Medicine, Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center
Verified email at mskcc.org
Title
Cited by
Cited by
Year
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
LB Saltz, JV Cox, C Blanke, LS Rosen, L Fehrenbacher, MJ Moore, ...
New England Journal of Medicine 343 (13), 905-914, 2000
39432000
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study
LB Saltz, S Clarke, E Díaz-Rubio, W Scheithauer, A Figer, R Wong, ...
Journal of clinical oncology 26 (12), 2013-2019, 2008
37162008
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
RM Samstein, CH Lee, AN Shoushtari, MD Hellmann, R Shen, ...
Nature genetics 51 (2), 202-206, 2019
30662019
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ...
Nature medicine 23 (6), 703-713, 2017
29122017
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor
LB Saltz, NJ Meropol, PJ Loehrer Sr, MN Needle, J Kopit, RJ Mayer
Journal of clinical oncology 22 (7), 1201-1208, 2004
22542004
OncoKB: a precision oncology knowledge base
D Chakravarty, J Gao, S Phillips, R Kundra, H Zhang, J Wang, ...
JCO precision oncology 1, 1-16, 2017
19292017
MethyLight: a high-throughput assay to measure DNA methylation
CA Eads, KD Danenberg, K Kawakami, LB Saltz, C Blake, D Shibata, ...
Nucleic acids research 28 (8), e32-00, 2000
17412000
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
GK Abou-Alfa, L Schwartz, S Ricci, D Amadori, A Santoro, A Figer, ...
Journal of clinical oncology 24 (26), 4293-4300, 2006
15632006
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry
KY Chung, J Shia, NE Kemeny, M Shah, GK Schwartz, A Tse, A Hamilton, ...
Journal of clinical oncology 23 (9), 1803-1810, 2005
14032005
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer
J Cassidy, S Clarke, E Díaz-Rubio, W Scheithauer, A Figer, R Wong, ...
Journal of clinical oncology 26 (12), 2006-2012, 2008
10812008
American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options
LE Schnipper, NE Davidson, DS Wollins, C Tyne, DW Blayney, D Blum, ...
Journal of Clinical Oncology 33 (23), 2563, 2015
9842015
Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology
AB Benson, AP Venook, MM Al-Hawary, MA Arain, YJ Chen, KK Ciombor, ...
Journal of the National Comprehensive Cancer Network 19 (3), 329-359, 2021
9222021
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803
JA Meyerhardt, D Heseltine, D Niedzwiecki, D Hollis, LB Saltz, RJ Mayer, ...
J Clin Oncol 24 (22), 3535-3541, 2006
9122006
NCCN guidelines insights: colon cancer, version 2.2018
AB Benson, AP Venook, MM Al-Hawary, L Cederquist, YJ Chen, ...
Journal of the National Comprehensive Cancer Network 16 (4), 359-369, 2018
8642018
Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology
AB Benson, AP Venook, MM Al-Hawary, L Cederquist, YJ Chen, ...
Journal of the National Comprehensive Cancer Network 16 (7), 874-901, 2018
8612018
Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology
AB Benson, AP Venook, L Cederquist, E Chan, YJ Chen, HS Cooper, ...
Journal of the National Comprehensive Cancer Network 15 (3), 370-398, 2017
7572017
PD-1 blockade in mismatch repair–deficient, locally advanced rectal cancer
A Cercek, M Lumish, J Sinopoli, J Weiss, J Shia, M Lamendola-Essel, ...
New England Journal of Medicine 386 (25), 2363-2376, 2022
7562022
Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer
S Kopetz, J Desai, E Chan, JR Hecht, PJ O'Dwyer, D Maru, V Morris, ...
Journal of clinical oncology 33 (34), 4032, 2015
7262015
Hepatic neuroendocrine metastases: does intervention alter outcomes?
RS Chamberlain, D Canes, KT Brown, L Saltz, W Jarnagin, Y Fong, ...
Journal of the American College of Surgeons 190 (4), 432-445, 2000
7072000
Clinical sequencing defines the genomic landscape of metastatic colorectal cancer
R Yaeger, WK Chatila, MD Lipsyc, JF Hechtman, A Cercek, ...
Cancer cell 33 (1), 125-136. e3, 2018
6762018
The system can't perform the operation now. Try again later.
Articles 1–20